Literature DB >> 19286647

ABCA1 plays no role in the centripetal movement of cholesterol from peripheral tissues to the liver and intestine in the mouse.

Chonglun Xie1, Stephen D Turley, John M Dietschy.   

Abstract

This study uses the mouse to explore the role of ABCA1 in the movement of this cholesterol from the peripheral organs to the endocrine glands for hormone synthesis and liver for excretion. The sterol pool in all peripheral organs was constant and equaled 2,218 and 2,269 mg/kg, respectively, in abca1(+/+) and abca1(-/-) mice. Flux of cholesterol from these tissues equaled the rate of synthesis plus the rate of LDL-cholesterol uptake and was 49.9 mg/day/kg in control animals and 62.0 mg/day/kg in abca1(-/-) mice. In the abca1(+/+) animals, this amount of cholesterol moved from HDL into the liver for excretion. In the abca1(-/-) mice, the cholesterol from the periphery also reached the liver but did not use HDL. Fecal excretion of cholesterol was just as high in abac1(-/-) mice (198 mg/day/kg) as in the abac1(+/+) animals (163 mg/day/kg), although the abac1(-/-) mice excreted relatively more neutral than acidic sterols. This study established that ABCA1 plays essentially no role in the turnover of cholesterol in peripheral organs or in the centripetal movement of this sterol to the endocrine glands, liver, and intestinal tract for excretion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19286647      PMCID: PMC2694331          DOI: 10.1194/jlr.M900024-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  67 in total

1.  NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes.

Authors:  Rodney E Infante; Michael L Wang; Arun Radhakrishnan; Hyock Joo Kwon; Michael S Brown; Joseph L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-04       Impact factor: 11.205

2.  A PEST deletion mutant of ABCA1 shows impaired internalization and defective cholesterol efflux from late endosomes.

Authors:  Wengen Chen; Nan Wang; Alan R Tall
Journal:  J Biol Chem       Date:  2005-06-10       Impact factor: 5.157

3.  Receptor-mediated and bulk-phase endocytosis cause macrophage and cholesterol accumulation in Niemann-Pick C disease.

Authors:  Benny Liu; Chonglun Xie; James A Richardson; Stephen D Turley; John M Dietschy
Journal:  J Lipid Res       Date:  2007-05-02       Impact factor: 5.922

4.  GM2/GD2 and GM3 gangliosides have no effect on cellular cholesterol pools or turnover in normal or NPC1 mice.

Authors:  Hao Li; Stephen D Turley; Benny Liu; Joyce J Repa; John M Dietschy
Journal:  J Lipid Res       Date:  2008-04-30       Impact factor: 5.922

5.  Centripetal cholesterol flux to the liver is dictated by events in the peripheral organs and not by the plasma high density lipoprotein or apolipoprotein A-I concentration.

Authors:  C D Jolley; L A Woollett; S D Turley; J M Dietschy
Journal:  J Lipid Res       Date:  1998-11       Impact factor: 5.922

6.  Liver X receptor activation enhances cholesterol loss from the brain, decreases neuroinflammation, and increases survival of the NPC1 mouse.

Authors:  Joyce J Repa; Hao Li; Tamy C Frank-Cannon; Mark A Valasek; Stephen D Turley; Malú G Tansey; John M Dietschy
Journal:  J Neurosci       Date:  2007-12-26       Impact factor: 6.167

7.  Intestinal ABCA1 directly contributes to HDL biogenesis in vivo.

Authors:  Liam R Brunham; Janine K Kruit; Jahangir Iqbal; Catherine Fievet; Jenelle M Timmins; Terry D Pape; Bryan A Coburn; Nagat Bissada; Bart Staels; Albert K Groen; M Mahmood Hussain; John S Parks; Folkert Kuipers; Michael R Hayden
Journal:  J Clin Invest       Date:  2006-03-16       Impact factor: 14.808

8.  Cholesterol balance and metabolism in mice with loss of function of Niemann-Pick C protein.

Authors:  C Xie; S D Turley; P G Pentchev; J M Dietschy
Journal:  Am J Physiol       Date:  1999-02

9.  Marked reduction in bile acid synthesis in cholesterol 7alpha-hydroxylase-deficient mice does not lead to diminished tissue cholesterol turnover or to hypercholesterolemia.

Authors:  M Schwarz; D W Russell; J M Dietschy; S D Turley
Journal:  J Lipid Res       Date:  1998-09       Impact factor: 5.922

10.  Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages.

Authors:  Xuewei Zhu; Ji-Young Lee; Jenelle M Timmins; J Mark Brown; Elena Boudyguina; Anny Mulya; Abraham K Gebre; Mark C Willingham; Elizabeth M Hiltbold; Nilamadhab Mishra; Nobuyo Maeda; John S Parks
Journal:  J Biol Chem       Date:  2008-06-14       Impact factor: 5.157

View more
  28 in total

Review 1.  Crosstalk between reverse cholesterol transport and innate immunity.

Authors:  Kathleen M Azzam; Michael B Fessler
Journal:  Trends Endocrinol Metab       Date:  2012-03-10       Impact factor: 12.015

Review 2.  A new framework for reverse cholesterol transport: non-biliary contributions to reverse cholesterol transport.

Authors:  Ryan-E Temel; J-Mark Brown
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

3.  Multiple mechanisms limit the accumulation of unesterified cholesterol in the small intestine of mice deficient in both ACAT2 and ABCA1.

Authors:  Stephen D Turley; Mark A Valasek; Joyce J Repa; John M Dietschy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-08-19       Impact factor: 4.052

4.  Cholesterol auxotrophy and intolerance to ezetimibe in mice with SREBP-2 deficiency in the intestine.

Authors:  Shunxing Rong; Jeffrey G McDonald; Luke J Engelking
Journal:  J Lipid Res       Date:  2017-06-19       Impact factor: 5.922

5.  ABCA1 promotes the efflux of bacterial LPS from macrophages and accelerates recovery from LPS-induced tolerance.

Authors:  Patricia A Thompson; Karine C Gauthier; Alan W Varley; Richard L Kitchens
Journal:  J Lipid Res       Date:  2010-05-15       Impact factor: 5.922

Review 6.  A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion.

Authors:  Ryan E Temel; J Mark Brown
Journal:  Trends Pharmacol Sci       Date:  2015-04-27       Impact factor: 14.819

7.  In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1.

Authors:  Adriaan G Holleboom; Lily Jakulj; Remco Franssen; Julie Decaris; Menno Vergeer; Joris Koetsveld; Jayraz Luchoomun; Alexander Glass; Marc K Hellerstein; John J P Kastelein; G Kees Hovingh; Jan Albert Kuivenhoven; Albert K Groen; Scott M Turner; Erik S G Stroes
Journal:  J Lipid Res       Date:  2013-05-06       Impact factor: 5.922

Review 8.  Developmental and extrahepatic physiological functions of SREBP pathway genes in mice.

Authors:  Luke J Engelking; Mary Jo Cantoria; Yanchao Xu; Guosheng Liang
Journal:  Semin Cell Dev Biol       Date:  2017-07-20       Impact factor: 7.727

Review 9.  Cholesterol, the central lipid of mammalian cells.

Authors:  Frederick R Maxfield; Gerrit van Meer
Journal:  Curr Opin Cell Biol       Date:  2010-06-02       Impact factor: 8.382

10.  Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid.

Authors:  Benny Liu; Charina M Ramirez; Anna M Miller; Joyce J Repa; Stephen D Turley; John M Dietschy
Journal:  J Lipid Res       Date:  2009-11-18       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.